Bergen COVID-19 Research Group

covid_19_group_logo


The Bergen COVID-19 Research: Pioneering Research That Shapes Policy

Our group is a dynamic team of scientists dedicated to unraveling the complexities of COVID-19. Beyond researchers, we are an important link between science and society.

Our group is a dynamic team of scientists dedicated to unraveling the complexities of COVID-19. Beyond researchers, we are an important link between science and society.

➢ Our Impact: Guiding Global Responses

Our early findings have significantly influenced national and international COVID-19 policies. From reducing transmission in households to uncovering long COVID in mild cases, our research aids decision-makers.

➢ Vaccine Insights: Protecting Communities

Our clinical trials on COVID-19 vaccine responses has played a pivotal role in understanding immunity. We've identified the need for booster shots in high risk groups,  particularly with the emergence of variants like Delta and Omicron, ensuring enhanced protection for all.

➢ Educating the Public: Sharing Knowledge

Our contributions extend beyond groundbreaking research. We actively educate students, scientists, and healthcare workers through webinars and public engagement initiatives, both locally, nationally and on the global stage.

➢ Connecting with Communities: Trustworthy Outreach

We serve as a trusted source of scientific knowledge in the media, providing clarity amid uncertainty. Our online presence, including our dedicated website and public engagement initiatives, reaches diverse audiences.

➢  Policy Advice: Guiding Key Organizations

Our experts advise influential organizations, including the WHO, EU and the European Commission. We've contributed to shaping public health strategies, including scientific opinions on pandemics.

Future-Ready: Prepared for What Lies Ahead

Our multidisciplinary team is well-prepared to tackle future outbreaks, epidemics, and pandemics. With ongoing projects and a commitment to pandemic preparedness, we're poised to meet the challenges of tomorrow.

Explore our ongoing research and discoveries as we continue our mission to understand COVID-19 and contribute to a safer world.

Members of the group

Professor Rebecca Cox, Head of the Influenza Centre

Rebecca Jane Cox Brokstad

Professor, PhD. PI and Head of the Influenza Centre

Foto: Svein Lunde, Helse Stavanger

Nina Langeland

Professor, MD, PhD, Medical PI

Kristin

Kristin Greve-Isdahl Mohn

Associate Professor, MD, PhD. Specialist in Infection Medicine

Bjørn

Bjørn Blomberg

Associate Professor, MD, PhD. Specialist in Infection Medicine 

Karl

Karl A. Brokstad

Professor, Dr. Sc. Immunologist and lab. coordinator

 

Other group members

Arild Iversen (Bergen Municipality)

Kjell Haug (Bergen Municipality, Department of Global Public Health and Primary Care (IGS))

Bård Kittang (Department of Clinical Science (K2), Bergen Municipality, Haraldsplass Deaconess Hospital (HDS))

Dagrun Waag Linchhausen

Iren Löhr (K2, Stavanger University Hospital (SUS))

Heidi Syre (SUS)

Marianne Sævik (Haukeland University Hospital (HUS))

Camilla Tøndel (K2 HUS)

Fan Zhou (K2)

UiBlogoMED_gray_m
Logo-Norsk
Haraldsplass
Logo-RGB-bredde-Bergenkommune
logo_Helse_Stavanger_engelsk_positiv_Windows
klinbeforsk_logo-300x87
standard_hvl
FHU
brl-logo-hd_transparent

Sponsors

The-Research-Council-of-Norway
TMS_eng_rgb
social
klinbeforsk_logo-300x87
en_USEnglish